Dean Capital Management’s ICU Medical ICUI Stock Holding History

Dean Capital Management’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,465	Closed	-$713K	–	139
2019 Q3	$713K	Buy	+4,465	New	+$889K	0.74%	53

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nitorum Capital New York $114M AUM 17.21% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FPP

Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return

Dean Capital Management's ICUI Position: Q4 2019 in Review

Dean Capital Management sold out of ICU Medical (ICUI) in Q4 2019, closing a stake of 4,465 shares — an estimated $713K sold.

Dean Capital Management first reported a position in ICUI in Q3 2019 and held it in 1 quarter. The position peaked at $713K in Q3 2019. 267 funds tracked by Wall St. Rank hold ICUI as of Q4 2019.

Dean Capital Management reported no remaining ICU Medical position as of Q4 2019 after selling out during the quarter.
Dean Capital Management sold 4,465 ICU Medical shares in Q4 2019, an estimated $713K.
Dean Capital Management first reported a position in ICU Medical in Q3 2019 and held it in 1 quarter.
Dean Capital Management's ICU Medical position peaked at $713K in Q3 2019.
267 funds tracked by Wall St. Rank held ICU Medical as of Q4 2019.

Based on Dean Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.